
Karplat 450mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Carboplatin (450mg)
Overview Karplat 450mg Injection
Cisplatin 450mg Injection is indicated for the management of ovarian and small cell lung cancers. Its mechanism of action involves inhibiting or retarding cancerous cell proliferation. Administered intravenously under strict medical supervision, the dosage and frequency are determined by the treating physician based on individual needs and may vary. Adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent, potentially requiring weeks or months; discontinuation should only occur under medical guidance. Common side effects include nausea, emesis, weariness, and elevated hepatic enzymes. A reduction in blood cell counts (erythrocytes and leukocytes) can increase vulnerability to infection and hemorrhage. Report fever, pharyngitis, rigors, unusual bleeding or ecchymosis, and dark urine to your physician immediately. Regular hematological monitoring, along with cardiac, hepatic, and uric acid level assessments, is essential. Allergic reactions, such as dermatological eruptions, pruritus, and respiratory distress, necessitate immediate medical attention. Drug interactions are possible; therefore, comprehensive disclosure of all medications to your healthcare provider is mandatory. This injection is contraindicated during gestation and lactation. Employing effective contraception for both partners throughout treatment is imperative to prevent conception.
Uses of Karplat 450mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Karplat 450mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Karplat 450mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Karplat 450mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Karplat 450mg Injection works:
The injection Karplat 450mg is an antineoplastic agent. Its mechanism of action involves disrupting the DNA and RNA of cancerous cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Karplat 450mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Karplat 450mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Medical advice is essential.
Breast feedingUNSAFE
Administering Karplat 450mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Karplat 450mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Karplat 450mg Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Kidney function should be regularly assessed during treatment with this medication.
LiverSAFE IF PRESCRIBED
The use of Karplat 450mg Injection in patients with liver impairment is likely safe. Available evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Karplat 450mg Injection :
Omit a Karplat 450mg Injection dose? Seek your physician's advice.
Facts to Know About Karplat 450mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Behavioral Class | Platinum-based anticancer agents |
